The Clarithromycin Tablets, cataloged under National Stock Number 6505-01-354-8581, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Chartwell Rx Llc. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 4 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-354-8581 |
| Primary Part Number | NDC62135-0615-60 |
| Item Name | Clarithromycin Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Chartwell Rx Llc |
| Status | ACTIVE |
| Primary Container Content Quantity | 60.000 TABLETS |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 500.000 MILLIGRAMS CLARITHROMYCIN ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC62135-0615-60 PRIMARY | Chartwell Rx Llc (USA) |
| NDC00781-1962-60 PRIMARY | Sandoz Inc. (USA) |
| Reference | Meaning |
|---|---|
| NDC00527-1932-06 | 5/9 Secondary reference U.S. Government activity |
| NDC00527-1932-06 | 5/9 Secondary reference Cencora, Inc. |
| 10163577 | 5/9 Secondary reference Cencora, Inc. |
| NDC57237-0045-60 | 5/9 Secondary reference Citron Pharma Llc |
NSN 6505-01-354-8581 is a Clarithromycin Tablets, manufactured by Chartwell Rx Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-354-8581 has 2 manufacturer part numbers on file: NDC62135-0615-60 (Chartwell Rx Llc), NDC00781-1962-60 (Sandoz Inc.).
Key specifications for NDC62135-0615-60: Primary Container Content Quantity: 60.000 TABLETS; Primary Container Type: BOTTLE; Special Features: FOR USE IN MISCELLANEOUS B LACTAM ANTIBIOTICS. STORE AT 20-25 DEG C(68-77 DEG F)(SEE USP CONTROLLED ROOM TEMPERATURE) DEGC; Part Name Assigned by Controlling Agency: CLARITHROMYCIN TABLETS 500MG 60S BT. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.